Phase 2 Trial of Epcoritamab in Combination With Rituximab-mini CVP for Older Unfit/Frail Patients or Anthracycline-Ineligible Adult Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Condition:   Large B-cell Lymphoma Interventions:   Drug: Prednisone;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Epcoritamab Sponsor:   M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials